NASDAQ:XAGE Longevity Health (XAGE) Stock Price, News & Analysis $0.31 0.00 (0.00%) As of 05/1/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsOwnershipSEC FilingsTrendsBuy This Stock About Longevity Health Stock (NASDAQ:XAGE) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Longevity Health alerts:Sign Up Key Stats Today's Range$0.31▼$0.3150-Day Range$0.25▼$0.5052-Week Range$0.23▼$8.27Volume20 shsAverage Volume2,878 shsMarket Capitalization$554.20 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania. Read More Receive XAGE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Longevity Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. XAGE Stock News HeadlinesLongevity Health Holdings Closes Strategic Investment and Appoints Ram Ajjarapu as Chairman and CEO to Drive Acquisition-Focused GrowthMarch 17, 2026 | globenewswire.comLongevity Health Holdings Ends Merger with True HealthDecember 12, 2025 | tipranks.comI was right about SpaceXJeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,000%. Now he says SpaceX is shaping up to be the biggest IPO of the decade - and three key milestones just confirmed it. In the past 21 days: SpaceX crossed 10,000 active satellites, Elon filed confidential IPO paperwork with the SEC, and another rocket launched 25 more satellites. Two-thirds of every satellite in orbit now belongs to one company. The public filing could drop any day.May 5 at 1:00 AM | Brownstone Research (Ad)Why Longevity Health Stock Is Skyrocketing TodayJuly 15, 2025 | benzinga.comWhy Longevity Health Stock Is Skyrocketing TodayJuly 15, 2025 | benzinga.comLongevity Health Holdings, Inc.: Longevity Health Holdings Announces Merger with THPlasma and Termination of 20/20 BioLabs TransactionJuly 15, 2025 | finanznachrichten.deLongevity Health Holdings to Merge With True HealthJuly 15, 2025 | marketwatch.comLongevity Health stock soars after merger with THPlasma in all-stock dealJuly 15, 2025 | investing.comSee More Headlines XAGE Stock Analysis - Frequently Asked Questions How have XAGE shares performed this year? Longevity Health's stock was trading at $0.3009 at the beginning of the year. Since then, XAGE shares have increased by 3.4% and is now trading at $0.3110. How were Longevity Health's earnings last quarter? Longevity Health Holdings, Inc. (NASDAQ:XAGE) issued its earnings results on Thursday, August, 14th. The company reported ($1.56) earnings per share for the quarter. The firm had revenue of $0.50 million for the quarter. How do I buy shares of Longevity Health? Shares of XAGE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings8/14/2025Today5/05/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorManufacturing Industry Surgical, Medical, And Dental Instruments And Supplies Sub-IndustryMedical Equipment Current SymbolNASDAQ:XAGE CIK1842939 WebN/A Phone(412) 894-8248FaxN/AEmployees14Year FoundedN/AProfitability EPS (Trailing Twelve Months)($5.06) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$10.37 million Net Margins-682.67% Pretax Margin-691.89% Return on EquityN/A Return on Assets-261.90% Debt Debt-to-Equity RatioN/A Current Ratio0.47 Quick Ratio0.30 Sales & Book Value Annual Sales$1.05 million Price / Sales0.53 Cash FlowN/A Price / Cash FlowN/A Book Value($6.77) per share Price / Book-0.05Miscellaneous Outstanding Shares1,782,000Free Float1,265,000Market Cap$554.20 thousand OptionableN/A Beta0.28 Elon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free Report This page (NASDAQ:XAGE) was last updated on 5/5/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | SponsoredYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSell 99% of Your Stocks, Do THIS Instead…Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...The Oxford Club | SponsoredTrade this between 9:30 and 10:45 am ESTThe first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...Base Camp Trading | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredElon Unveils AI Passive Income Stream for Millions of AmericansDuring Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Longevity Health Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Longevity Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.